You Searched For "remdesivir" and got 16 results
Sort By:
Remain alert says Union Health Minister as India records 3,038 fresh Covid-19 cases
"We need to remain alert but there is no need to worry. Currently, the sub-variant of Omicron which…
ANI
Remdesivir could reduce Covid mortality if given within 9 days of symptom onset, says new study
Remdesivir can reduce mortality in patients if administered within 9 days of COVID-19 symptom onset…
PTI
These are the companies that are making Remdesivir in India
Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…
Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study
Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
Lymphoma drug outperforms Remdesivir against COVID-19 virus
A chemotherapy medication originally developed to treat lymphoma has outperformed the popular remde…
Saptagir partners with Jubliant Generics to manufacture 'Remdesivir'
The drug will be produced at its Hyderabad WHO-GMP certified sterile drug product manufacturing …
Remdesivir linked to reduced risk of death in severe Covid-19 patients
This is an important finding that requires confirmation in prospective clinical trials, Gilead s…
Cipla says COVID-19 drug Remdesivir will hit market this week
As India faces a shortage of Covid-19 drug Remdesivir, the pharmaceutical company Cipla said it wil…
The curious case of Remdesivir — the coronavirus ‘miracle drug’ may be overhyped, suggests Lancet study
Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases (NIAID)…
Gilead sold $873 million worth of its antiviral COVID-19 treatment even though data on its success remains mixed
Gilead posted its first numbers detailing how much money the pharmaceutical company has made throug…
Allana Akhtar
The first approved COVID-19 drug is far from 'amazing'
These are Business Insider's biggest healthcare stories for October 26.
Lydia Ramsey Pflanzer
What it'll take to get a vaccine to Americans
These are the top stories written by Business Insider's healthcare team for the week ending October…
Lydia Ramsey Pflanzer
Gilead's remdesivir just got the first FDA approval to be used as a treatment for coronavirus patients
Gilead Sciences just received approval from the US Food and Drug Administration to use its antivira…
Allana Akhtar
See the pitch deck a healthcare startup founded by 2 ex-Googlers used to raise $47 million
These are Business Insider's biggest healthcare stories for October 19.
Lydia Ramsey Pflanzer
Remdesivir proved to be the first useful tool we have in treating COVID-19 patients. Now, the US government wants to find out more about how it could be supercharged with other drugs.
The National Institutes of Health announced a massive new study Friday to test 3 immune modulators …